Biblio Discovery — Demo Discovery Service

3 results for "Stephan R. Bohl"

Showing 1–3 · 0.35 seconds · RSS

  1. Journal Article

    Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

    Danielle S. Potter; Ruochen Du; Stephan R. Bohl et al.

    Nature Communications, Vol. 14 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Malignant pleural mesothelioma (MPM) has relatively ineffective first/second-line therapy for advanced disease and only 18% five-year survival for early disease. Drug-induced mitochondrial priming measured by dynamic BH3 profiling identifies efficacious drugs in multiple disease settings…

  2. Journal Article

    Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma

    Yuen Lam Dora Ng; Evelyn Ramberger; Stephan R. Bohl et al.

    Nature Communications, Vol. 13 No. 1 · 2022 · English · DOAJ Scopus

    Acquired resistance to immunomodulatory drugs is common in multiple myeloma patients, but rarely attributed to genetic alterations. Here, proteomic, phosphoproteomic and RNA sequencing analysis in five paired pre-treatment and relapse samples reveals a CDK6-regulated protein resistance signature.